Viatris Inc. Executive Chairman Robert J. Coury will become chairman emeritus and senior strategic adviser to the company in December, the pharmaceutical company announced Monday.
Mr. Coury, who oversaw the transition of Mylan N.V into privately held Viatris, which employs some 38,000 people, will continue to advise the company in a non-employee capacity until the end of 2025. The Viatris board will pick a new independent chair, who will be announced in the coming months and whose tenure will begin after the company’s annual meeting of shareholders in December.
“I am very pleased to be in a position to plan a clear and orderly transition for the company,” Mr. Coury said in a prepared statement.
Mylan, a storied global generic and specialty pharmaceutical company, was founded in 1961 in an abandoned skating rink in White Sulphur Springs, W.Va., and went public in 1973. In 2020, Mylan, which has offices in Southpointe, Cecil Township and elsewhere, merged with Upjohn, Pfizer’s off-patent medicine division to form Viatris.
Kris B. Mamula: kmamula@post-gazette.com





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.